Company
United StatesSafrel Pharmaceuticals LLC, Dayton, NJ – FDA Inspections
Inspection records and compliance data for Safrel Pharmaceuticals LLC in Dayton, NJ. 1 FDA inspection on record, 1 Form 483, 1 warning letter, last inspected January 30, 2026.
Company Profile
This profile covers Safrel Pharmaceuticals LLC based in Dayton, NJ, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 1
Inspected January 30, 2026.
Most cited issue areas
- Absence of Written Procedures1 inspection
- Buildings of Suitable Size, Construction, Location1 inspection
- Distribution Recall System1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 30, 2026 | Not classified | Foods & Cosmetics, Human Drugs | 1300468 |
FDA documents
Form 483s (1)
Warning Letters (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Safrel Pharmaceuticals LLC
FEI Number
3042030663
Address
178 Ridge Rd Ste H, Dayton, NJ 08810-2532, United States
Country
United States
ID: 3656e327-293c-4e9f-86df-6fd8e00ce1f1